High blood sugar powers an experimental implant that helps improve glucose control in diabetes
Key Points:
- Researchers have developed NeuroAxis, an experimental implant powered by a glucose fuel cell that monitors blood sugar levels in real time and stimulates the vagus nerve to regulate metabolism and inflammation in diabetes patients.
- Unlike existing electroceuticals, NeuroAxis harvests energy directly from glucose in surrounding tissue, eliminating the need for external batteries or wireless charging, and delivers electrical pulses when blood sugar remains high.
- In rat models of type 1 and type 2 diabetes, the implant promoted pancreatic beta-cell growth, improved insulin sensitivity, normalized blood sugar levels, and reduced inflammation and fat accumulation, with effects lasting weeks after stimulation ceased.
- The device functions as an artificial neuroimmune axis, restoring communication between the nervous, immune, and metabolic systems that is often disrupted in diabetes, potentially offering a novel approach to treating metabolic disorders.
- Researchers note that further improvements in the biofuel cell's stability and threshold settings are needed before NeuroAxis can be used for long-term treatment.